Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research on the Prevention and Treatment of Liver Fibrosis/Cirrhosis with Spirulina Tablets and Its Mechanisms

NCT06770283 is registered in ClinicalTrials.gov with Second Affiliated Hospital, Zhejiang University, School of Medicine as lead sponsor.

NCT NCT06770283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06770283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research on the Prevention and Treatment of Liver Fibrosis/Cirrhosis with Spirulina Tablets and Its Mechanisms
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 26, 2024
Completion date
December 26, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis